- 2020.10.06 GeneQuest participates in the 3rd Shonan Conference launched under the theme of "perinatal depression" by Shonan Health Innovation Park
-
2020.10.06
(Correction) Notice regarding shareholder benefit program
We would like to inform you that the content of the preferential treatment system in the "Notice Concerning the Shareholder Benefit System" disclosed on August 21, 2020 has been partially changed due to the product renewal.
The corrected parts are marked with a red frame and double underlined.2. 2. Details of the shareholder benefit program
(2) Special treatment contents
A catalog where you can purchase the following products designated by us (1 product of 100 shares or more and less than 500 shares, 2 products of 500 shares or more) and products designated by us at a special discount price according to the number of shares you own. * Will be presented.
* Special discounts for shareholders are set for each product of health foods, cosmetics and gene analysis services listed in the catalog (10% discount is usually up to 30% discount for regular purchases of health foods and cosmetics). .. In addition, as an environmentally friendly initiative, we will abolish sending catalogs in paper booklets and guide you to browse online.<Before correction>
Over 100 shares:
"Euglena for the body Green Powder 1week" + Presentation of a catalog that allows you to purchase our designated products at a special discount price
Over 500 shares:
"Euglena for the body Green Powder 1week" and "Euglena for the body Green Tablet (28 tablets)" + Presentation of a catalog that allows you to purchase our designated products at a special discount price<After correction>
Over 100 shares:
"Euglena for the body Green Powder 1week" + Presentation of a catalog that allows you to purchase our designated products at a special discount price
Over 500 shares:
"Euglena for the body Green Powder 1week" and "Euglena for the body Green Tablet (42 tablets)" + Presentation of a catalog that allows you to purchase our designated products at a special discount price -
2020.09.29
A paper on joint research with RIKEN on Euglena non-swimming mutants was published in the international academic journal "PeerJ".
On September 28, 2020, Euglena non-swimming mutants was published in the international academic journal "PeerJ".
Using the method of inducing mutations in the Euglena genome by heavy ion beam irradiation, which was developed in collaboration with RIKEN, we will create a mutant that permanently lacks the swimming ability, which is one of the characteristics of Euglena I succeeded in doing so. In addition, through detailed analysis of the mutant, it was confirmed that Euglena
By utilizing the precipitation-prone property of this mutant, it is expected that not only the development that simplifies the harvesting process after culturing will be possible, but also that it will be a material that can be used for various academic research applications.
Click here for details (English treatise) -
2020.09.18 BCAD
Wins Top Spa Cosmetics in Cosmetics category at "Crystal Award 2020"
On September 16, 2020, the "Crystal Award 2020" (co-sponsored by Spa & Wellness Japan and Concept Asia Co., Ltd.) will be awarded to the facilities and brands that have gained the most support in the spa and wellness industry by voting by spa users. BCAD was selected as the top spa cosmetics in the cosmetics category.
In the top spa category, ANA Intercontinental Ishigaki Resort Spa Agarosa, who uses BCAD, has been selected as Japan's top spa.
Click here for details -
2020.09.18
A paper on the identification of Euglena with Saga University was published in the international academic journal "Natural Product Communications".
On August 31, 2020, a paper on the identification of monohexosylceramide contained in the Euglena with Saga University was published in the international academic journal "Natural Product Communications".
Ceramide is a major component of intercellular lipids in the epidermal layer of the skin, and its concentration is said to be reduced in patients with atopic dermatitis and psoriasis. Therefore, application of ceramide as a cosmetic ingredient contributes to maintaining the water content of the skin epidermis and maintaining the skin barrier function. It is also known that ingestion of ceramide as a food ingredient relieves atopic dermatitis symptoms. It is known that the structure of ceramide varies greatly depending on the species from which it is derived.
In a paper reported in collaboration with Professor Hiroshi Kitagaki of Saga University, monohexosylceramide was identified and reported from the lipid fraction derived from Euglena
We will continue to Euglena the health food and medical fields and increasing the added value of ingredients and cosmetics.Click here for details (English treatise)